Teva reports seventh straight quarter of growth
Teva Pharmaceutical Industries Limited (New York Stock Exchange: Tifa; level: Tifa It ended the third quarter with revenue of $4.33 billion and non-GAAP earnings per share of $0.69, beating the consensus of analysts who…